HK Stock Market Move | CNBM (03323) rose more than 6%. Institutions predict that the profitability of the new materials business is expected to continue to improve this year.
China Building Materials (03323) rose more than 6%, as of the time of publication, up 6.68% to HK$5.11, with a turnover of HK$261 million.
CNBM (03323) rose more than 6%, as of press time, it has risen by 6.68%, to 5.11 Hong Kong dollars, with a turnover of 2.61 billion Hong Kong dollars.
On the news front, driven by the explosive growth of AI computing power, the special electronic cloth sector continues to boom, with some ordinary cloth production capacity being converted to special cloth. The overall supply and demand in the industry is tight, and prices of all types of electronic cloth are on an upward trend. Huatai previously indicated that the company's new materials sector's revenue in 2025 was 55.557 billion yuan, an increase of 14.4% year-on-year, with an operating profit of 6.258 billion yuan, an increase of 11.8% year-on-year. In terms of products, the sales volume/average price of fiberglass increased by 3.1%/12.8% respectively year-on-year, achieving a simultaneous increase in volume and price. Ordinary and high-performance electronic cloth are expected to open up new growth opportunities for the fiberglass sector. With the completion of the world's first zero-carbon intelligent manufacturing fiberglass base, the production of high-performance electronic cloth continues to increase, and it is expected that the profitability of the new materials business in 2026 will continue to improve.
Related Articles

New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.

New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.

New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.
New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.

New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.

New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.






